Literature DB >> 30951171

Phosphorylation of Forkhead Protein FoxO1 at S253 Regulates Glucose Homeostasis in Mice.

Kebin Zhang1, Xiaoqin Guo2, Hui Yan1, Yuxin Wu1,3, Quan Pan1, James Zheng Shen1, Xiaopeng Li1, Yunmei Chen1, Ling Li1, Yajuan Qi1, Zihui Xu1, Wei Xie2, Weiping Zhang1, David Threadgill1, Ling He4, Daniel Villarreal1, Yuxiang Sun1, Morris F White5, Hongting Zheng2, Shaodong Guo1.   

Abstract

The transcription factor forkhead box O1 (FoxO1) is a key mediator in the insulin signaling pathway and controls multiple physiological functions, including hepatic glucose production (HGP) and pancreatic β-cell function. We previously demonstrated that S256 in human FOXO1 (FOXO1-S256), equivalent to S253 in mouse FoxO1 (FoxO1-S253), is a key phosphorylation site mediating the effect of insulin as a target of protein kinase B on suppression of FOXO1 activity and expression of target genes responsible for gluconeogenesis. Here, we investigated the role of FoxO1-S253 phosphorylation in control of glucose homeostasis in vivo by generating global FoxO1-S253A/A knockin mice, in which FoxO1-S253 alleles were replaced with alanine (A substitution) blocking FoxO1-S253 phosphorylation. FoxO1-S253A/A mice displayed mild increases in feeding blood glucose and insulin levels but decreases in fasting blood glucose and glucagon concentrations, as well as a reduction in the ratio of pancreatic α-cells/β-cells per islet. FoxO1-S253A/A mice exhibited a slight increase in energy expenditure but barely altered food intake and glucose uptake among tissues. Further analyses revealed that FoxO1-S253A/A enhances FoxO1 nuclear localization and promotes the effect of glucagon on HGP. We conclude that dephosphorylation of S253 in FoxO1 may reflect a molecular basis of pancreatic plasticity during the development of insulin resistance.
Copyright © 2019 Endocrine Society.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30951171      PMCID: PMC6482038          DOI: 10.1210/en.2018-00853

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  38 in total

1.  Inactivation of specific β cell transcription factors in type 2 diabetes.

Authors:  Shuangli Guo; Chunhua Dai; Min Guo; Brandon Taylor; Jamie S Harmon; Maike Sander; R Paul Robertson; Alvin C Powers; Roland Stein
Journal:  J Clin Invest       Date:  2013-07-01       Impact factor: 14.808

Review 2.  CREB and the CRTC co-activators: sensors for hormonal and metabolic signals.

Authors:  Judith Y Altarejos; Marc Montminy
Journal:  Nat Rev Mol Cell Biol       Date:  2011-03       Impact factor: 94.444

Review 3.  Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms.

Authors:  Shaodong Guo
Journal:  J Endocrinol       Date:  2014-01-08       Impact factor: 4.286

4.  Inhibition of Foxo1 function is associated with improved fasting glycemia in diabetic mice.

Authors:  Jennifer Altomonte; Anja Richter; Sonal Harbaran; Jenny Suriawinata; Jun Nakae; Swan N Thung; Marcia Meseck; Domenico Accili; Hengjiang Dong
Journal:  Am J Physiol Endocrinol Metab       Date:  2003-06-03       Impact factor: 4.310

5.  Dysregulation of insulin receptor substrate 2 in beta cells and brain causes obesity and diabetes.

Authors:  Xueying Lin; Akiko Taguchi; Sunmin Park; Jake A Kushner; Fan Li; Yedan Li; Morris F White
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

6.  Pancreatic β cell dedifferentiation as a mechanism of diabetic β cell failure.

Authors:  Chutima Talchai; Shouhong Xuan; Hua V Lin; Lori Sussel; Domenico Accili
Journal:  Cell       Date:  2012-09-14       Impact factor: 41.582

7.  Glucagon as a critical factor in the pathology of diabetes.

Authors:  Dale S Edgerton; Alan D Cherrington
Journal:  Diabetes       Date:  2011-02       Impact factor: 9.461

8.  Legacy Effect of Foxo1 in Pancreatic Endocrine Progenitors on Adult β-Cell Mass and Function.

Authors:  Shivatra Chutima Talchai; Domenico Accili
Journal:  Diabetes       Date:  2015-03-17       Impact factor: 9.461

9.  Obestatin stimulates glucose-induced insulin secretion through ghrelin receptor GHS-R.

Authors:  Geetali Pradhan; Chia-Shan Wu; Jong Han Lee; Preeti Kanikarla; Shaodong Guo; Vijay K Yechoor; Susan L Samson; Yuxiang Sun
Journal:  Sci Rep       Date:  2017-04-20       Impact factor: 4.379

10.  Prolyl carboxypeptidase in Agouti-related Peptide neurons modulates food intake and body weight.

Authors:  Giuseppe Bruschetta; Sungho Jin; Jung Dae Kim; Sabrina Diano
Journal:  Mol Metab       Date:  2018-02-08       Impact factor: 7.422

View more
  4 in total

Review 1.  Role of Forkhead Box Protein O1 (FoxO1) in Stroke: A Literature Review.

Authors:  Sichao Guo; Ruchi Mangal; Chaitu Dandu; Xiaokun Geng; Yuchuan Ding
Journal:  Aging Dis       Date:  2022-04-01       Impact factor: 6.745

Review 2.  Perspectives on benefit of early and prereperfusion hypothermia by pharmacological approach in stroke.

Authors:  Fengwu Li; Jie Gao; Wesley Kohls; Xiaokun Geng; Yuchuan Ding
Journal:  Brain Circ       Date:  2022-06-30

Review 3.  Alterations of Gut Microbiota by Overnutrition Impact Gluconeogenic Gene Expression and Insulin Signaling.

Authors:  Ling He
Journal:  Int J Mol Sci       Date:  2021-02-20       Impact factor: 5.923

Review 4.  Insulin action at a molecular level - 100 years of progress.

Authors:  Morris F White; C Ronald Kahn
Journal:  Mol Metab       Date:  2021-07-15       Impact factor: 8.568

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.